Lasa Supergenerics Limited — Others, 25-02-2025: Shareholders meeting

Lasa Supergenerics Limited has announced a board meeting regarding the results of the Extraordinary General Meeting (EOGM) held on February 22, 2025. The scrutinizer's report confirms that the resolution to approve the issue of convertible warrants on a preferential basis was passed with a significant majority, as 99.98% of votes were in favor. This approval could enhance the company's capital-raising strategy, potentially fueling future growth. Investors may view this as a positive outlook, given the strong support for the proposal, which could strengthen shareholder value and confidence in management’s strategic direction.